TURKU, Finland, November 6 /PRNewswire/ -- BioCis Pharma Ltd a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. The double-blind, vehicle-controlled study is designed to evaluate the tolerability and efficacy of the topical product in a total of 18 subjects with mild to moderate forms of atopic dermatitis. The subjects will apply ProtoCure(TM) emulsion cream up to four weeks to the skin areas affected by the disease.

VANCOUVER, Canada, November 6 /PRNewswire/ -- Burcon NutraScience Corporation (TSX-V: BU) announces today the appointment of BMO Capital Markets to act as exclusive financial advisor to Burcon in connection with a process to identify and pursue strategic alternatives for the commercialization of its innovative food technology.

In engaging BMO Capital Markets, Burcon is initiating an extensive review of alternative strategies for maximizing shareholder value arising from Burcon's intellectual property portfolio including the recently announced soy protein isolate technology and CLARISOY(TM).

NOVATO, California, November 6 /PRNewswire/ --

- Enters Collaboration on Receptor Associated Protein (RAP)

- Supports NeuroTrans(TM) Platform with Japanese Patent

Raptor Pharmaceuticals Corp. (Raptor or the Company) (OTC Bulletin Board: RPTP), today announced updates on its preclinical program which utilizes drug-targeting platforms derived from the human receptor-associated protein (RAP) and related proteins. The Company signed a collaborative research agreement with the Brigham and Women's Hospital involving the characterization of certain modified RAP proteins. At the Hospital, this research will be conducted in the laboratory of Dr. Stephen Blacklow. The Company has also announced today a patent issuance in Japan relating to the NeuroTrans(TM) program.

LONDON, November 6 /PRNewswire/ -- New research published by the UK's largest trade union, Unite, shows investigation levels into major injuries to workers have declined by 43% between 2001/2 and 2006/7. In 2006/7, the last year when statistics are available, only 10.5% of major injuries reported to the Health and Safety Executive (HSE) were investigated.

The research, undertaken by the Centre for Corporate Accountability for Unite, also shows that in the same five year period there has been a 69% reduction in the number of worker 'over-three day' injuries investigated, a 31% decline in the number of 'dangerous occurrences' investigated, and a 68% decline in the number of members of the public injuries investigated.

HELSINKI, November 6 /PRNewswire/ --

- Orascom Telecom Subsidiary Will use Comptel Solution to Improve Fulfillment Processes for Mobile Services

Comptel Corporation (OMX Helsinki: CTL1V), the leading vendor of dynamic Operations Support System (OSS) software, announced today that Algerian mobile operator Orascom Telecom Algerie OTA (Djezzy), a fully owned subsidiary of Orascom Telecom Holding, has selected Comptel Provisioning and Activation Solution. This deal follows the announcements in 2007 of Comptel being chosen as preferred supplier by Orascom Telecom, and of the subsequent selection by Orascom joint venture Tunisiana.

ORLANDO, Florida, November 6 /PRNewswire/ -- The QAI Global Institute (http://www.qaiworldwide.com), which administers Software Certifications' examinations, after having certified more than 35,000 professionals worldwide in 43 countries on the international standard for software quality and testing practitioner certifications, Certified Software Quality Analyst (CSQA) and Certified Software Tester (CSTE), announced the launch of two of their new certifications: Certified Associate in Software Quality (CASQ) and the Certified Associate in Software Testing (CAST).

VIENNA, Austria, November 6 /PRNewswire/ --

- Looking Like 35 at 50 - Thanks to New Cosmetic Surgery!

Plastic surgery, facelifts, and lid correction have been typical for ageing Hollywood stars. Now they're going out of fashion. Recently, media reported that stars now rely on New Cosmetic Surgery to rejuvenate their face and shape.

In New Cosmetic Surgery age-related changes in face and body are being treated not by lifting and silicon, but by the use of body-own, stem-cell-enriched fat.

KVISTGARD, Denmark, November 6 /PRNewswire/ -- Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE(R) in HIV infected subjects that confirms the excellent safety profile of IMVAMUNE(R). Within the next few days the safety report of this study will be submitted to the FDA and this will trigger a USD 25 million milestone payment under the RFP-3 contract. The clinical safety report constitutes a major part of the data package that will be used to potentially support the use of IMVAMUNE(R) in a declared emergency.

LONDON, November 6 /PRNewswire/ --

- At Last, Gloves That are Compatible With Your iPhone, iPod Touch and Other Touch-Screen Devices!

- With Photo

BEIJING, November 6 /PRNewswire/ --

Addintools Technology LTD announces the release of Ribbon Customizer for Office 2007, a powerful customization tool for Microsoft Office 2007. Ribbon Customizer for Office 2007 allows users to tweak the ribbon in multiple Office 2007 applications, providing the ability to add, remove, and reorder controls on the ribbon and the main menu. The new tool allows for fine-tuning of the appearance of various Office applications to allow employees, students or home businesses to achieve their tasks faster and more conveniently. The easy deployment to large numbers of workstations makes Ribbon Customizer for Office 2007 an ideal solution for large businesses and enterprises as well as home offices and end-users.